Mirae Asset Global Etfs Holdings Ltd. Arvinas, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 38,636 shares of ARVN stock, worth $258,474. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,636
Previous 36,514
5.81%
Holding current value
$258,474
Previous $699,000
61.23%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARVN
# of Institutions
246Shares Held
62.5MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$55.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$41.9 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$25.9 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$25.6 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$22.3 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $356M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...